Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief
Executive Officer, Robert E. Conway, will speak at the Leerink Swann
Conquering Cancer with Novel Therapeutics: Roundtable Conference on May
9 in New York City. The public is welcome to participate in the
conference through a webcast on the Array BioPharma website.
Event:
Leerink Swann Conquering Cancer with Novel Therapeutics: Roundtable
Conference
Presenter:
Robert E. Conway, Chief Executive Officer, Array BioPharma
Date:
Friday, May 9, 2008
Time:
9:20 a.m. Eastern Time
Location:
The Grand Hyatt New York, New York City
Webcast:
www.arraybiopharma.com
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small molecule
drugs to treat patients afflicted with cancer, inflammatory diseases and
pain. Our proprietary drug development pipeline includes clinical
candidates that are designed to regulate therapeutically important
target proteins and are aimed at significant unmet medical needs. In
addition, leading pharmaceutical and biotechnology companies collaborate
with Array to discover and develop drug candidates across a broad range
of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
|